What is chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?

CIDP is an uncommon autoimmune condition. The body targets its own tissues when it has an autoimmune illness. The body assaults the myelin sheaths in CIDP. These are the fatty coatings that envelop and shield the nerve fibres.

Experts believe that Guillain-Barr syndrome (GBS), a more well-known illness, is linked to CIDP. Most people agree that GBS is an acute, short-term illness. CIDP is regarded as a chronic, long-term illness. Compared to GBS, CIDP is less prevalent.

Typically, CIDP is categorised as follows:

• Progressive: Over time, the illness keeps getting worse.
• Recurrent: Symptom episodes come and go.
• Monophasic: This indicates that the illness only recurs once every one to three years.

Who is at risk for CIDP?

CIDP can happen to anyone. However, compared to other age groups, those in their 50s and 60s appear to have a higher chance of developing it. The disease is twice as common in men as in women.

What are the symptoms of CIDP?

Symptoms are generally alike for all subtypes of CIDP. Common symptoms include:

• Tingling in the limbs
• Gradual weakness of arms and legs
• Loss of reflexes
• Difficulty with balance or walking
• A loss of feeling in the limbs, often commencing with being unable to perceive a pinprick

What causes CIDP?

CIDP is when the immune system of the body attacks the myelin sheaths surrounding the peripheral nervous system's nerve cells. These are nerves outside the brain and spinal cord. But what causes this is not known. Unlike GBS, there is typically no infection that precedes CIDP. CIDP does not seem to have a hereditary component.

How does one diagnose CIDP?

Due to its rarity, CIDP is frequently difficult to diagnose, at least initially. Because of the similarities between the two conditions, medical professionals may mistake its symptoms for those of GBS. A medical professional may consider CIDP if symptoms persist for more than eight weeks.

Following taking a medical history and performing a physical and neurological exam, the medical professional will conduct at least two more tests to help diagnose the case. These could include:

• Blood and urine tests
• A nerve conduction study and an electromyogram: These are measures of myelin damage in the peripheral nerves by applying mild electrical currents to the nerve and testing the response as well as nerve function.
• A lumbar puncture: A lumber puncture is used to check for abnormally high amounts of specific disease-related proteins. This is accomplished by inserting a tiny needle into the back and drawing out a tiny quantity of the cerebrospinal fluid, which surrounds the spinal cord.
• Nerve biopsy: A nerve biopsy to examine minute alterations in the nerves. Seldom is this test conducted.
• MRI: Inflammation of the nerve roots may be shown on an MRI. The roots are the location where the nerve separates from the spinal cord.

How is CIDP treated?

For the most part, the treatment for CIDP is effective. Indeed, some research suggests that as many as 4 out of 5 people's symptoms improve with treatment. The autoimmune nature of the disease often means healthcare providers use immunosuppressive medicines to treat CIDP. Because each person's experience is different, medical teams will tailor your treatment and monitor your progress closely. Treatments for CIDP include:

• Immunosuppressive medicines
• Steroids
• Intravenous or subcutaneous immunoglobulin
• Plasma exchange (plasmapheresis)
• Monoclonal antibody therapy

Can I prevent CIDP?

As researchers don't know what causes CIDP, there is no known way to prevent its development.

What is the prognosis for people with CIDP?

Numerous factors influence the long-term prognosis or outlook, such as:

• Your age at the start of CIDP.
• The type of variation and the way the ailment progresses.
• The speed at which you are diagnosed and treated.
• How the treatment initially affects your body.

With a 50% chance of relapsing, 90% of CIDP patients respond to treatment. For those with CIDP who receive a diagnosis earlier in life, the long-term outlook is generally favourable. You risk developing irreversible nerve damage that leaves you disabled if you don't get treatment for CIDP.

Your medical professional will be able to give you more precise information about what to expect based on your specific situation.

How long is the survival time of an individual with CIDP?

CIDP is not a fatal condition, and an individual with CIDP has an almost similar survival time as any other person.

When should I visit my doctor?

In case you are diagnosed with CIPD, you will be required to see your doctor more often to observe the symptoms of the disease. CIPD symptoms may also recur after several months or even years, necessitating continuous treatment.

When should I go to the ER?

Rarely, CIPD can involve muscles that you need to breathe with. If you find it difficult to breathe you need to call your local emergency services number or go to your local emergency room.

Why Tender Palm Super-Speciality Hospital for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?

Tender Palm Hospital, owned by doctors, is renowned for attracting the most experienced professional in the country, with the finest neurologist and neurosurgeons specialized in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Tender Palm stands out as the premier Neurology hospital in Lucknow, India. Boasting cutting-edge infrastructure and advanced technology, Tender Palm ensures top-notch medical care for its patients.

To Book an appointment for chronic inflammatory demyelinating polyradiculoneuropathy

Call us at +91-9076972161
Email at care@tenderpalm.com

Request a Call Back